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1Prognosis after acute myocardial infarction (MI) is pri-marily dictated by the extent of irreversible myocardial 
injury and by left ventricular (LV) remodeling. Numerous 
mechanical, macrovascular, microvascular, and biochemi-
cal factors are known to contribute to the early myocardial 
changes after ischemia reperfusion.1 Despite the advanced 
knowledge of the pathophysiology of ischemia reperfusion, 
the translation of these findings into effective clinical thera-
pies has been limited in the past.1 Thanks to the continuous 
technical developments, research has now moved to a new 
and more complex level: major efforts are being invested 
in identifying novel advanced cardioprotective strategies 
aiming to modify the genetic profile and the function of 
cells involved in the early infarct expansion.2 The efficacy 
of such complex and expensive treatments will also depend 
Background—CMR T1 mapping is a quantitative imaging technique allowing the assessment of myocardial injury 
early after ST-segment–elevation myocardial infarction. We sought to investigate the ability of acute native T1 
mapping to differentiate reversible and irreversible myocardial injury and its predictive value for left ventricular 
remodeling.
Methods and Results—Sixty ST-segment–elevation myocardial infarction patients underwent acute and 6-month 
3T CMR, including cine, T2-weighted (T2W) imaging, native shortened modified look-locker inversion recovery 
T1 mapping, rest first pass perfusion, and late gadolinium enhancement. T1 cutoff values for oedematous versus 
necrotic myocardium were identified as 1251 ms and 1400 ms, respectively, with prediction accuracy of 96.7% (95% 
confidence interval, 82.8% to 99.9%). Using the proposed threshold of 1400 ms, the volume of irreversibly damaged 
tissue was in good agreement with the 6-month late gadolinium enhancement volume (r=0.99) and correlated 
strongly with the log area under the curve troponin (r=0.80) and strongly with 6-month ejection fraction (r=−0.73). 
Acute T1 values were a strong predictor of 6-month wall thickening compared with late gadolinium enhancement.
Conclusions—Acute native shortened modified look-locker inversion recovery T1 mapping differentiates reversible 
and irreversible myocardial injury, and it is a strong predictor of left ventricular remodeling in ST-segment–elevation 
myocardial infarction. A single CMR acquisition of native T1 mapping could potentially represent a fast, safe, and 
accurate method for early stratification of acute patients in need of more aggressive treatment. Further confirmatory 
studies will be needed.  (Circ Cardiovasc Imaging. 2017;10:e005986. DOI: 10.1161/CIRCIMAGING.116.005986.)
Key Words: magnetic resonance imaging ◼ microcirculation ◼ myocardial infarction ◼ ventricular remodeling
Circ Cardiovasc Imaging is available at http://circimaging.ahajournals.org DOI: 10.1161/CIRCIMAGING.116.005986
© 2017 The Authors. Circulation: Cardiovascular Imaging is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, 
Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any 
medium, provided that the original work is properly cited.
Received November 28, 2016; accepted July 12, 2017.
From the Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Headley Way, United Kingdom 
(D.L., A.B., D.V., M.A., G.L.D.M., G.F., S.D., R.W., J.F., V.F., S.P., M.D.R., R.C., S.N., E.D.A.); Department of Cardiovascular Medicine, Oxford Heart Centre, 
John Radcliffe Hospital, Headley Way, United Kingdom (A.B., K.C., R.K.); and Department of Radiology, Brigham and Women’s Hospital, Boston, MA (M.J.-H.). 
The Data Supplement is available at http://circimaging.ahajournals.org/lookup/suppl/doi:10.1161/CIRCIMAGING.116.005986/-/DC1.
Correspondence to Erica Dall’Armellina, MD, Leeds Institute of Cardiovascular and Metabolic Medicine, Division of Biomedical Imaging, University 
of Leeds, LIGHT Building, Clarendon Way, Leeds, LS2 9JT, United Kingdom. E-mail E.DallArmellina@leeds.ac.uk
CMR Native T1 Mapping Allows Differentiation  
of Reversible Versus Irreversible Myocardial Damage  
in ST-Segment–Elevation Myocardial Infarction
An OxAMI Study (Oxford Acute Myocardial Infarction)
Dan Liu, PhD; Alessandra Borlotti, PhD; Dafne Viliani, MD;  
Michael Jerosch-Herold, PhD; Mohammad Alkhalil, MRCP, MD;  
Giovanni Luigi De Maria, MD; Gregor Fahrni, MD; Sam Dawkins, MBBS;  
Rohan Wijesurendra, MB BChir; Jane Francis, DCR(R), DNM; Vanessa Ferreira, MD, DPhil;  
Stefan Piechnik, PhD; Matthew D. Robson, PhD; Adrian Banning, MD;  
Robin Choudhury, DM; Stefan Neubauer, MD; Keith Channon, MD; Rajesh Kharbanda, MD;  
Erica Dall’Armellina, MD, DPhil
Myocardial Infarction
See Editorial by Garg and Plein 
See Clinical Perspective
 by guest on A
ugust 22, 2017
http://circim
aging.ahajournals.org/
D
ow
nloaded from
 
 by guest on A
ugust 22, 2017
http://circim
aging.ahajournals.org/
D
ow
nloaded from
 
 by guest on A
ugust 22, 2017
http://circim
aging.ahajournals.org/
D
ow
nloaded from
 
 by guest on A
ugust 22, 2017
http://circim
aging.ahajournals.org/
D
ow
nloaded from
 
 by guest on A
ugust 22, 2017
http://circim
aging.ahajournals.org/
D
ow
nloaded from
 
 by guest on A
ugust 22, 2017
http://circim
aging.ahajournals.org/
D
ow
nloaded from
 
 by guest on A
ugust 22, 2017
http://circim
aging.ahajournals.org/
D
ow
nloaded from
 
 by guest on A
ugust 22, 2017
http://circim
aging.ahajournals.org/
D
ow
nloaded from
 
2  Liu et al  T1 Mapping to Assess Severity of Myocardial Injury 
on the availability of accurate quantitative diagnostic tech-
niques, such as cardiovascular magnetic resonance (CMR).3 
CMR imaging is considered the gold standard noninvasive 
imaging technique for myocardial tissue characterization 
and quantification of acute and chronic myocardial injury 
after MI. However, late gadolinium enhancement (LGE) 
for the assessment of acute necrotic myocardium4 is partly 
hampered by methodological and technical challenges.5,6 
Parametric mapping methods are becoming the techniques 
of choice for quantitative voxel-based tissue characteriza-
tion postrevascularization because of their major diagnostic 
accuracy.7–9 During ischemia reperfusion, the deterioration 
of the microvascular function and endothelial structure are 
crucial determinants of the degree of cellular damage and 
water molecule exchange.10 Native T1 mapping techniques 
provide a quantitative biomarker of intracellular and extra-
cellular environments of the myocardium without the need 
for intravenous contrast agents; native T1 mapping accu-
rately depicts myocardial edema in the area at risk after 
an acute ischemic event.11,12 Furthermore, initial evidence 
would suggest that native T1 mapping might allow for 
assessment of severity of injury and prediction of recov-
ery.8 The use of native T1 mapping to distinguish reversible 
(namely oedematous myocardium) and irreversible injury 
(namely necrotic myocardium as assessed by LGE) post-
acute MI without use of contrast, would be of major clinical 
use, in that it would not only be safer in patients with kidney 
impairment and would shorten the scan time (by avoiding 
contrast-based techniques) but would also potentially allow 
for an early accurate stratification of those acute patients in 
need of more aggressive treatment.13
We sought to investigate (1) whether acute native T1 
mapping distinguishes reversible oedematous versus irrevers-
ible necrotic myocardial injury and (2) the predictive value 
of native T1 mapping for 6-month functional recovery over 
standard CMR measures of infarct size and microvascular 
function.
Methods
Patient Population
The study protocol was approved by the local ethics committee, 
and all patients gave written informed consent. Sixty ST-segment–
elevation MI patients undergoing primary percutaneous coronary 
intervention (PPCI) within 12 hours of symptoms onset were pro-
spectively enrolled as part of the OxAMI study (Oxford acute myo-
cardial infarction). ST-segment–elevation MI was defined as per 
current guidelines.14 Acute clinical management reflected contempo-
rary practice and guidelines (further details in the Data Supplement). 
Troponin I was assessed pre-PPCI (n=50) and at 6 (n=57), 24 (n=57) 
and 48 hours (n=52) post-PPCI; area under the curve was calculated 
using the trapezoidal rule to express this as summary measure of in-
farct size.15
Cardiac Magnetic Resonance Protocol
CMR was performed on a 3 Tesla MR scanner (either MAGNETOM 
TIMTrio or MAGNETOM Verio; Siemens Healthcare, Erlangen, 
Germany) acutely (12–96 hours post-PPCI) and at 6 months. The 
CMR protocol (details in the Data Supplement) included cine, T2-
prepared steady state free precession imaging, native shortened modi-
fied look-locker inversion recovery (ShMOLLI) T1 mapping, LGE, 
and first pass perfusion.
CMR Imaging Analysis
Anonymized images were analyzed using cvi42 software (Circle 
Cardiovascular Imaging, Inc, Calgary, Canada) by experienced op-
erators. LV function, segmental wall thickening (WT), quantification 
of edema, myocardial blood flow (MBF), and LGE were performed 
as described previously.16 The signal intensity threshold indicating 
myocardial edema was set at 2 SD above the remote reference region 
of interest (ROI); full width at half maximum technique was used on 
LGE.17 Microvascular obstruction (MVO) or hemorrhage were defined 
as the low-intensity core within an area of LGE or T2W imaging and 
were included in the reported areas of infarction or edema, respective-
ly. Furthermore, LGE MVO was assessed separately and expressed 
as a percentage of total LV mass. LGE transmurality was assessed as 
described previously.16 T1 maps underwent strict and extensive quality 
control as described previously.8 Segmental T1 values were derived 
from short-axis T1 maps using in-house dedicated software MC-ROI 
(Interactive Data Language, version 6.1; Exelis Visual Information 
Solutions, Boulder, CO; Further details in the Data Supplement).
Native T1 Analysis—ROI-Based Analysis: 
Derivation Cohort and Validation Cohort
Patients were randomly partitioned (with a ratio of 5:1) into 2 groups: 
a derivation cohort (n=50) for threshold identification and a valida-
tion cohort (n=10) for method validation and proof of concept as de-
scribed previously.18
Derivation Cohort
ROI-based T1 analyses were performed using cvi42 software on LV 
short-axis slices with no MVO or hemorrhage. To define the distribution 
of T1 values in areas of infarcted versus salvaged myocardium (defined 
as the oedematous regions adjacent to the LGE), ROIs were manually 
drawn on the threshold-enhanced area on acute LGE (ROI T1LGEpos) (Figure 1C) and transferred onto the corresponding acute matching 
ShMOLLI T1 map; edema was identified on T1 maps by using a thresh-
old of 2 SD threshold above the remote normal myocardium.8 ROIs 
were then manually drawn on the salvaged myocardium (ROI T1
edema). 
Anatomic landmarks ensured matching of the corresponding areas as 
published previously.13 The identified T1 values were used to establish 
cutoff thresholds for reversible (T1
rev
) and irreversible injuries (T1irrev).
Using the same principle, 6-month T1 values in the myocardium 
corresponding to the enhanced area of LGE 6-month could be identi-
fied (ROI T1
scar
).
Proof of Concept: Validation Cohort
Using the identified T1 thresholds, an expert MRI-trained cardi-
ologist blinded to the LGE and edema analysis performed thresh-
old-based analysis on ShMOLLI T1 maps on a different set of 
10 patients to identify regions of irreversible injury on acute T1 
maps (Figure 1E). If visually identified, MVO areas were included 
in the lesion size.
Statistical Analysis
All analyses were performed using Matlab 2014a and R 3.2.3. 
Continuous variables were expressed as mean±SD (except where 
specified otherwise). Categorical variables were expressed as n 
(%). Normality was checked by Shapiro–Wilks test. Student t test 
(paired and unpaired) was used for comparison of continuous vari-
ables. Nonparametric Kruskal–Wallis with Dunn test was used to (1) 
compare differences in mean T1 values in in predefined ROIs (ROI 
T1LGEpos versus ROI T1edema versus ROI T1remote) and (2) assess the in-
dependence of T1 acute on the degrees of LGE transmurality (<50%, 
50% to 75%, >75%) because normality of data was violated. One-
way ANOVA with Tukey–Kramer test was used to compare multiple 
means of segmental MBF values in 3 subgroups partitioned accord-
ing to T1 cutoff values as reversible injury (T1
rev
), irreversible injury 
(T1irrev), and remote (T1remote), when data normality and homogene-
ity of variances were met. Max-t test for multiple comparisons ad-
justed for unequal variances was adopted to compare (1) segmental 
6-month WT in subgroups split according to T1 cutoff values and (2) 
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3  Liu et al  T1 Mapping to Assess Severity of Myocardial Injury 
multiple T1 means in the ROIs of acute T1LGEpos, 6-month T1LGEpos, 
acute T1
remote, as heteroscedasticity was observed. Correlation was 
expressed as Pearson correlation coefficient. Bonferroni method 
was adopted to adjust P values in the Dunn test to control family-
wise error rate. Classification tree analysis was adopted to detect T1 
thresholds. The criteria for validation of the T1 thresholds is given 
in the Data Supplement. Exhaustive best-subset predictor selection 
approach19 was used to determine the best multivariable linear re-
gression model to predict 6-month WT based on 3 predictors, that is, 
MBF, LGE, and T1 mapping at 24 hours. The relative importance of 
predictors (summing to 100%) was assessed by relative importance 
metric of covariate, LMG,20 which was calculated using R package 
relaimpo. Moreover, the multivariable logistic regression model was 
used to predict 6-month WT, using a 40% cutoff. Similarly, MBF, 
LGE, and T1 mapping at 24 hours were chosen as potential baseline 
independent variables. Receiver-operating characteristic analysis was 
performed to assess model performance of logistic regression.
Results
Patient characteristics are given in Table 1. Seventy patients 
were screened: 10 were excluded (including 5 points where 
imaging protocol could not be completed because of patients’ 
lack of compliance and 5 points with breathing artifacts on acute 
T1 maps). One patient missed his follow-up scan at 6-month.
CMR findings are summarized in Table 2. There was no 
significant difference between measurements of the area of 
edema using T1 mapping and T2W (difference of 1.5±6.0% 
per slice, P=0.09, and 2.0±6.7% per-patient basis, P=0.38).
Acute T1 Native Mapping Predicts Reversible 
Versus Irreversible Myocardial Injury—ROI 
Analysis
For the ROI-based T1 analysis of reversible versus irreversible 
injury, 58 acute short-axis slices without MVO were available 
of which 43 had matching 6-month T1 maps.
ROI-based analysis on the derivation cohort was used to 
assess the acute native T1 values in areas of necrosis versus 
edema versus remote. T1 values were significantly differ-
ent with T1LGEpos=1447±44 ms, T1edema=1327±36 ms, and 
T1
remote=1177±34 ms (P<0.001; Figure 2A). By applying a 
decision tree model to the above derived T1s, the cutoff T1 
values for oedematous (T1
rev
) versus remote (T1
remote) and 
oedematous versus necrotic myocardium (T1irrev) were identi-
fied as 1251 and 1400 ms, respectively (Figure 2B), with a 
prediction accuracy of 96.7 (95% confidence interval, 82.8% 
to 99.9%) with sensitivity 100%, 100%, and 91% and speci-
ficity 100%, 95%, and 100% for normal tissue, myocardial 
edema, and necrotic myocardium, respectively.
By using the proposed T1irrev threshold on the validation 
cohort, the volume of irreversibly damaged tissue was in good 
agreement with the 6-month LGE volume, both on a slice by 
slices basis (r=0.93; n=47; Figure 3A and 3B), and on per-
patient basis (r=0.99; n=10; Figure 3C and 3D).
Irreversible Injury Assessed by T1irrev Acute  
Cutoff Correlates With Area Under the  
Curve TnI Post-PPCI and 6-Month Ejection  
Fraction
Troponin I measurements at 4 time points were available in 
46 patients, of which 20 patients had full LV T1 map cov-
erage. For these 20 patients, there was a strong correlation 
between the volume of myocardial damage using acute T1irrev 
as threshold and log area under the curve troponin (r=0.80; 
Figure 4A and 4C). The correlation between 6-month ejec-
tion fraction and the amount of LV damage as assessed by 
acute T1irrev cutoff and LGE acute was strong (r=−0.73; Fig-
ure 4B and 4D).
Figure 1. Region of interest (ROI)-based analysis for assessment of T1 thresholds. A, Acute late gadolinium enhancement (LGE) showing 
septal positive enhancement; (B) acute native T1 map showing increased septal T1s; (C) Full width half maximum quantification of cor-
responding LGE myocardium ROI; (D) quantification of oedematous myocardium ROI on grayscale native T1 shortened modified look-
locker inversion recovery; (E) corresponding areas of edema and necrotic myocardium identified using T1 threshold values of 1400 ms 
(T1irrev) and 1250 ms (T1rev).
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The Healing of Myocardial Injury as Assessed by 
Changes in T1 Values From Acute to 6 Months, 
and Its Relationship to LGE and Resting MBF—
Segment-Based Analysis
To determine the changes in T1 from the acute to chronic stage, 
we assessed T1 values in the ROIs corresponding to the scarred 
myocardium as defined by full width at half maximum threshold 
analysis both in acute and at 6 months. The acute ROI T1LGEpos 
values were significantly higher than the 6-month ROI T1s 
(acute T1LGEpos=1451.7±45.9 ms; 6-month T1scar=1294.4±58.7 ms; 
P<0.001; Figure 5A and 5B), independent of the degree of LGE 
transmurality (Figure I in the Data Supplement); the relative 
reduction in ROI T1LGEpos values (ΔT1LGEpos acute-6 months) was 11±5% 
(range, −1% to 20%); 6 mol/L T1s were also significantly higher 
than the T1 values depicted in the remote myocardium (T1 remote 
myocardium=1173.4±34.2 ms; P<0.001; Figure 5A).
To assess whether the acute microvascular function played 
a role in the myocardial healing post-MI as defined by the T1 
changes over time, we first assessed the differences in acute 
MBF in myocardial segments reversible versus irreversible 
injury (defined by T1
rev
 and T1irrev thresholds). In non-MVO 
segments, MBF was significantly different between T1irrev, 
T1
rev
, and T1
remote segments (MBF=0.74±0.20 ml/min/g versus 
0.85±0.21 ml/min/g versus 0.93±0.22 ml/min/g, respectively; 
P<0.001; Figure 5C). Overall, there was a significant negative 
weak correlation between segmental MBF and segmental T1 
(r=−0.30) in acute MI; furthermore, in T1irrev segments, the 
magnitude of change in T1 values from acute to 6 months was 
greater in segments with less-impaired acute MBF (r=0.47; 
Figure 5D). In segments with MVO, MBF was significantly 
lower than in non-MVO T1irrev segments (MBF=0.59±0.18 
mL/min/g versus 0.74±0.20 mL/min/g; P<0.001).
Acute T1 Values Predict Functional Recovery at 6 
Months Over Standard CMR Techniques
In non-MVO segments, a moderate negative relationship 
between the 6-month WT and acute T1 values was found, 
using both segmental (r=−0.40) and threshold-based analysis 
(P<0.001; Figure 6A and 6B).
Table 1. Baseline Characteristics of the Study Population
 Mean±SD
Age, y 61±10
Men, n (%) 49 (82)
Risk factors, n (%)
  Smoking 18 (30)
  Diabetes mellitus 6 (10)
  Dyslipidemia 24 (40)
  Hypertension 24 (40)
  Family history of IHD 25 (42)
Peak troponin I, mg/L 133±190
Pain to balloon time, min 236±203
PPCI to CMR time, h 42±19
Culprit coronary artery, n (%)
  LAD 29 (48)
  RCA 28 (47)
  LCx 3 (5)
No. of vessels diseased, n (%)
  1 45 (75)
  2 11 (18)
  3 4 (7)
TIMI grade flow pre-PPCI, n (%)
  0 47 (78)
  1 5 (8)
  2 8 (13)
  3 0 (0)
TIMI grade flow post-PPCI, n (%)
  0 0 (0)
  1 0 (0)
  2 2 (3)
  3 58 (97)
Medications during PPCI
  GP IIb/IIIa inhibitor 13 (22)
  Bivalirudin 45 (75)
  Heparin 36 (60)
  Clopidogrel 6 (10)
Medications post-PPCI
  β-blockers 56 (93)
  ACE inhibitors 58 (97)
  Statins 60 (100)
  Aspirin 59 (98)
  Diuretic 4 (7)
  Nitrates 42 (70)
  Clopidogrel 45 (75)
  Ticagrelor 15 (25)
ACE indicates angiotensin-converting-enzyme; GP, glycoprotein; IHD, 
ischemic heart disease; LAD, left anterior descending; LCx, left circumflex; 
PPCI, primary percutaneous coronary intervention; RCA, right coronary artery; 
and TIMI, thrombolysis in myocardial infarction.
Table 2. CMR Findings
 
Acute,  
mean±SD  
(n=60)
6-month, 
mean±SD  
(n=59) P Value
EF, % 48±9 54±9 <0.001
EDV, mL 159±43 168±40 0.013
ESV, mL 84±31 78±31 0.009
LGE, FWHM (% LV) 27±12 17±9 <0.001
Edema by T2W, 2 SD (% LV) 41±14
Myocardial salvage (% LV T2W- 
6-month % LV LGE)
24±8
MVO on LGE n, (%) 31 (52%)
MVO (% LV) 2.8±3.0
P values were estimated using Student t test. EDV indicates end-diastolic 
volume; EF, ejection fraction; ESV, end-systolic volume; FWHM, full width 
half maximum; LGE, late gadolinium enhancement; LV, left ventricle; MVO, 
microvascular obstruction; and T2W, T2 weighted.
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Receiver-operating characteristic curves using a 40% 
cutoff for WT 6 months showed that T1 mapping and LGE 
were equally good predictors of 6-month WT (Figure 6C). 
By applying multivariable linear regression and variable 
importance share analysis (Figure 6D), results showed 
that the proportion to which T1 mapping accounts for the 
total explained WT variance is greater than LGE or MBF 
(44% versus 35% versus 21%, respectively). Furthermore, 
multivariable linear regression suggests that an increase 
in T1 values of 100 ms is significantly associated with a 
decrease in WT of 8% (95% confidence interval, 5% to 
11%; P<0.001).
Discussion
We explored the ability of acute native T1 mapping to dis-
tinguish reversible versus irreversible injury without the 
use of contrast media. Furthermore, we assessed the predic-
tive value of T1 mapping as determinants of long-term LV 
functional recovery compared with standard CMR tech-
niques. Our study has several main findings: (1) acute native 
Figure 2. Distribution of T1 values and 
identification of T1 thresholds. A, Mean 
T1 values in the remote, oedematous, 
and late gadolinium enhancement (LGE) 
myocardium on the derivation cohort; (B) 
classification tree model was applied to 
identify T1 acute threshold values T1rev 
and T1irrev.
Figure 3. Linear regression and Bland–Altman plots for comparison between acute irreversible volume by T1irrev threshold and 6-month 
FWHM late gadolinium enhancement (LGE). A and B, Per slice based analysis show a mean difference of ~2% and intraclass correlation 
ICC=0.92 with 95% confidence interval (CI; 0.86–0.95). C and D, Per patient-based analyses on matched volume show a mean difference 
of ~2% and ICC=0.97 with 95% CI (0.86–0.99). ICC indicates intraclass correlation coefficient; and FWHM, full width at half maximum.
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ShMOLLI T1 mapping allows accurate assessment of irre-
versibly injured myocardium, (2) T1 values decrease from 
acute to 6-month but remain higher than the remote allowing 
for assessment of scar at 6-month, (3) the severity of acute 
injury as expressed by increasingly higher T1 values, and the 
degree of myocardial healing assessed by change in T1 values 
Figure 4. Clinical validation of native 
T1irrev threshold. Correlation between the 
volume of irreversibly damaged myocar-
dium (as assessed by native acute T1irrev 
threshold or acute FWHM late gadolinium 
enhancement [LGE] or 6-month FWHM 
LGE) and the log area under the curve 
(AUC) of the troponin I (A and C) and the 
6-month ejection fraction (EF; B and D). 
FWHM indicates full width at half maxi-
mum technique; and LV, left ventricular.
Figure 5. T1 change from acute to 6 months, and its relation with myocardial blood flow (MBF) in nonmicrovascular obstruction seg-
ments. A, on 43 matched slices 6-month T1LGEpos is significantly lower than acute T1LGEpos but still higher than acute T1remote; (B) the change 
in T1 values is given for each measurement; (C) acute MBF is significantly different in T1irrev vs T1rev vs T1normal segments; (D) the segmental 
change of T1 from acute to 6 months ΔT1LGEpos acute-6 months significantly relates to the MBF.
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7  Liu et al  T1 Mapping to Assess Severity of Myocardial Injury 
from acute to 6 months, are associated to the acute microvas-
cular function (MBF), (4) the amount of acute myocardial 
irreversible injury assessed using native T1 mapping corre-
lates strongly with TnI and with 6-month ejection fraction, 
(5) native T1 mapping is a strong predictor of 6-month LV 
remodeling when compared with standard CMR techniques, 
such as MBF and LGE.
Native T1 Mapping at Acute Stage Post-MI Predicts 
Irreversibility of Injury
LGE is the clinical standard to assess scar volume in stable 
coronary artery disease.21 In the acute setting, LGE depicts 
myocardial necrosis,4 but its accuracy and hence clinical 
applicability has been repeatedly challenged.5,6,22 Careful 
timing of image acquisition postcontrast administration and 
careful postprocessing using stringent thresholds (such as full 
width at half maximum or 5 SD) are critical to avoid overes-
timation of the infarct size because of increased extracellular 
space in the peri-infarct zone.23,24 By determining voxel-wise 
T1 values on a continuous scale as measurements of the tis-
sue composition, native T1 mapping could potentially not 
only overcome the LGE limitations described above but 
also provide additional information on the severity of injury 
rather than just a volume of injury.8 Its additional diagnos-
tic value in quantifying ischemic myocardial oedema12 and 
the area at risk7 has been established. Pathology studies 
have demonstrated increasingly high T1 values in relation 
to the duration of ischemia25 and the consequent intra and 
extracellular molecular changes.26,27 We previously demon-
strated in a small cohort that elevated segmental T1 values 
significantly correlate to the transmural extent of 6-month 
LGE.8 However, the use of segmental analysis averages out 
the T1 values and hence lessens the effectiveness and clinical 
applicability of a voxel-wise quantitative technique. For the 
first time, the current new study provides a T1 cutoff value 
to differentiate edema (reversible injury) from more severe 
irreversible myocardial damage as depicted by full width at 
half maximum LGE at 24 hours postacute MI. Our data also 
show a strong correlation between the volume of irreversibly 
damaged myocardium as assessed by T1 and (1) the log area 
under the curve of the troponin I and (2) the ejection fraction 
at 6 months.
Changes in T1 Values From Acute to 6 Months
To assess the additional predictive value of T1 mapping 
compared with standard acute CMR imaging measures of 
Figure 6. Acute T1 and 6-month wall thickening (WT) in nonmicrovascular obstruction segments: relationship and predictive value. A, 
Moderate negative correlation between acute native T1s and 6-month WT (r=−0.40; n=689). B, 6-month WT (%) values are given in myo-
cardium defined by T1normal, T1rev, and T1irrev (69.0±30.3% vs 53.8±28.1% vs 38.5±17.6%; P<0.001). C, Receiver-operating characteristic 
curves for multivariable logistic regression using a 40% cutoff for dependent variable WT 6 months. Area under the curve for T1 mapping 
and late gadolinium enhancement (LGE) are similar and significantly better than myocardial blood flow (MBF). D, Relevant variable impor-
tance share to define the contribution of each predictor to the variation in 6-month WT (total explained WT variance ~20%) assessed 
using the LMG importance score (Data Supplement) in the multivariable linear regression: the T1 mapping contributes more to the predic-
tion of WT compared with LGE and MBF.
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infarct size and microvascular function, we first assessed 
the relationship between the changes in T1 values over time 
with LGE transmurality and MBF. Not only our results are 
consistent with previously published data demonstrating 
higher 6-month T1 values in scarred myocardium com-
pared with remote,16 in addition, we demonstrate a change 
in T1 values from acute to 6 months irrespective of the 
LGE transmurality. These findings validate the clinical use 
of native T1 values to detect irreversible myocardial injury 
acutely and most importantly distinguish it from chroni-
cally scarred myocardium. Furthermore, in patients with 
no evidence of MVO at LGE, we show a strong associa-
tion between the microvascular dysfunction post-PPCI and 
the higher T1 values and the magnitude of T1 change from 
acute to chronic.
MBF is a critical determinant of myocardial healing and 
an important target at the time of reperfusion to improve 
outcomes, as we have shown previously.28 Previous pathol-
ogy studies showed the existence of a delayed microvascular 
impairment,29 happening hours after reperfusion because of 
the accumulation of erythrocytes and neutrophils29 and dif-
ferent to the immediate no-reflow characterized by severe 
capillary damage with coagulation necrosis.30 Carrick et al9 
recently reported a progressively higher detection of myocar-
dial hemorrhage using T2* mapping from the early hours to 
first days after MI. It is plausible that even in patients with 
no evidence of immediate no-reflow as shown by LGE, the 
microvascular function deteriorates in the following 24 hours, 
leading to an inefficient myocardial healing process affecting 
LV remodeling.
The Additional Predictive Value of 6-month 
Functional Recovery of Native T1 Mapping 
Compared With LGE and MBF
We show that irreversibly injured myocardium as detected 
by T1 values shows the least WT at 6 months; both LGE 
and T1 mapping are strong predictors of 6-month recov-
ery in agreement with previously published data; however, 
our results show that T1 has a more relative importance as 
predictor of WT compared with LGE. These findings have 
important clinical significance. Currently, there is consid-
erable uncertainty on which standard imaging marker (ie, 
infarct size, MVO, and salvaged myocardium) carries the 
most prognostic weight. Establishing a valid predictor of 
long-term remodeling using the mere assessment of volumes 
of injury as biomarkers might be challenging because of the 
rapid changes happening in the tissue composition in the 
early hours post-PCI.31 Mapping techniques offer the poten-
tial additional advantage of quantifying exactly the expected 
change in long-term function based on the increase in acute 
T1 values. As such, T1 mapping would allow for an accurate 
stratification of patients who might need more aggressive or 
additional treatment to prevent remodeling. In a time where 
efforts are dedicated to developing novel therapies targeting 
the immune system early after the onset of ischemia, such 
additional diagnostic accuracy would play a key role in tai-
loring personalized treatments.
Study Limitations
The established T1 estimates and thresholds refer specifi-
cally to ShMOLLI T1 mapping technique at 3T scanners. 
Appreciable differences can be expected for other T1 map-
ping sequences and at different magnetic field strength. This 
is a proof of concept study that demonstrates the feasibility 
of T1 mapping to differentiate tissue and predict remodel-
ing assessed by surrogate end points, in mostly single vessel 
disease ST-segment–elevation MI patient. In this cohort, we 
have not assessed extracellular volume because this requires 
postcontrast T1 mapping and was perceived too challenging 
for imaging the MI patients in acute setting. Extracellular vol-
ume plays a crucial role in acute MI and healing of the myo-
cardium. Confirmatory studies on larger populations will be 
needed to assess the validity and applicability of our findings 
to all mapping methods at different fields strengths/vendors 
and to exploit the full clinical predictive value.
Conclusions
Native ShMOLLI T1 mapping performed in the early hours 
post-MI allows accurate assessment of the severity of myo-
cardial damage, and it differentiates reversible and irrevers-
ible injury. T1 mapping values are a stronger predictor of LV 
remodeling at 6 months compared with LGE. ShMOLLI T1 
mapping could represent a more accurate and faster noncon-
trast alternative to standard CMR LGE imaging in acute ST-
segment–elevation MI patients.
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CLINICAL PERSPECTIVE
Prognosis after acute myocardial infarction is primarily dictated by the degree of irreversible myocardial injury and by left 
ventricular remodeling. Future developments in identifying the efficacy of cardioprotective strategies will also depend on 
the availability of accurate diagnostic techniques. The applicability of standard late gadolinium enhancement techniques in 
the acute setting might be challenging because of the increased extracellular space and the well-known dynamic changes 
happening in the myocardium in the early hours of the healing stage. CMR mapping is becoming the technique of choice 
for quantitative voxel-based tissue characterization postrevascularization because of its major diagnostic accuracy. Such 
techniques offer a major potential advantage in allowing the assessment of the severity of injury rather than only a binary 
quantification of the injured volume and by doing so overcoming the challenges of late gadolinium enhancement in acute 
myocardial infarction. This study defines a cutoff value for native T1 mapping to distinguish reversible versus irreversible 
injury in acute myocardial infarction patients without need for contrast; furthermore, it shows the potential predictive value 
for long-term remodeling of acute T1 values. The translational clinical value of such findings is major in that it allows using 
a single scan acquisition to derive a biomarker relevant for risk assessment without need for multiple prolonged acquisitions 
or administration of contrast.
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Supplemental Material 
Patient population 
Diagnosis of STEMI required chest pain lasting longer than 30 min, within 12 h from onset of 
symptoms, and ST-segment elevation of ≥2 mm (0.2 mV) in at least 2 contiguous leads on 
ECG. Acute clinical management was at the discretion of the responsible physician, with the 
intention to reflected contemporary practice and guidelines.1 Exclusion criteria were 
presentation with cardiogenic shock, hemodynamic instability lasting >12 hours after 
revascularization, previous myocardial infarction, previous revascularization procedure 
(coronary artery bypass grafts or PCI), severe heart valve disease, cardiomyopathy, 
contraindications to CMR. 
CMR acquisition 
Matching short axis slices covering the LV were acquired using an established CMR protocol2,3 
including: cine, T2-prepared SSFP imaging, native Shortened Modified Look-Locker 
Inversion recovery (ShMOLLI) T1 mapping, and late gadolinium enhancement (LGE). In 
addition 3 to 5 short-axis images were acquired using First Pass Perfusion (FPP) imaging.Using 
T1 weighted FPP imaging, 3 to 5 short-axis images were acquired every heart beat to track the 
first pass of a gadolinium-based contrast agent (0.03 mmol/kg; gadoterate meglumine, Dotarem, 
Guerbet, Villepinte, France) injected at rest. LGE images were collected 10-15 min after the 
administration of 0.1 mmol/kg contrast agent (gadoterate meglumine, Dotarem, Guerbet, 
Villepinte, France). The inversion time was adjusted for optimal nulling of remote normal 
myocardium. 
T2W was performed using a T2-prep-SSFP single shot sequence with surface coil correction 
(TE/TR = 1/4.1 msec; effective TE = 60 msec; flip angle = 90°; voxel size: 2.1 × 1.6 × 8 mm). 
ShMOLLI T1 maps were generated from 5-7 SSFP images with variable inversion preparation 
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time as described previously.4 Typical acquisition parameters were: TE/TR = 1.07/2.14 msec, 
flip angle=35°, FOV=340×255mm, matrix size=192×144, 107 phase encoding steps, actual 
experimental voxel size = 1.8 × 1.8 × 8 mm, interpolated reconstructed voxel size = 0.9 × 0.9 
× 8 mm, GRAPPA = 2, 24 reference lines, cardiac delay time TD = 500 msec and 206 msec 
acquisition time for single image, phase partial Fourier 6/8.4 LGE was performed with a T1-
weighted segmented inversion recovery gradient echo-phase sensitive-inversion recovery 
(GRE_PSIR) sequence (TE/TR = 2.5 msec/5 msec, voxel size 1.8 × 1.4 × 8 mm, flip angle 
20°). Images were collected 10-15 min after the administration of 0.1 mmol/kg contrast agent 
(gadoterate meglumine, Dotarem, Guerbet, Villepinte, France). The inversion time was 
adjusted for optimal nulling of remote normal myocardium. SSFP cine images were acquired 
using retrospective gating (TE/TR = 1.4/3.2 msec; flip angle = 50°; voxel size: 1.6 × 1.6 × 8 
mm). Two to three-fold accelerated parallel imaging (GRAPPA) was used to shorten the 
breath-hold.  
For first pass perfusion (FPP) imaging, an ECG-gated T1-weighted (saturation-recovery 
prepared) fast gradient echo sequence was used (echo time, 1.04 msec; repetition time, 2 msec, 
saturation recovery time, 100 msec; voxel size, 2.1×2.6×8 mm3; flip angle, 17°) to acquire 3 
to 5 short-axis images every heart beat to track the first pass of a gadolinium-based contrast 
agent (0.03 mmol/kg; gadoterate meglumine, Dotarem, Guerbet, Villepinte, France) injected 
at rest. 
CMR image analysis 
Infarct size and myocardial oedema were expressed as a percentage of total LV mass; 
myocardial salvage was derived by subtracting the percentage infarct size from the percentage 
of myocardial oedema.2  
Segmental quantitative perfusion analysis was performed using an in-house Matlab software 
as previously described.5 Absolute myocardial blood flow (MBF) in ml/min/g was calculated 
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for each myocardial segment by Fermi-model constrained deconvolution of myocardial signal 
intensity curves with the arterial input.6,7 MBF was corrected for the heart rate –systolic blood 
pressure product.8,9  
Native T1 analysis- segment-based analysis 
T1 maps underwent strict and extensive quality control as previously described3 by 
investigating the native T1 maps, raw T1 images, R2 maps, considering off-resonance artefacts, 
partial volume effect, poor T1 fit on the R2 maps, patient movement or low SNR.10 Apical 
slices affected by partial volume effects and slices where the LV outflow tract was visible, 
were excluded from the study.  
Segmental T1 values were derived from short-axis T1 maps which were manually contoured 
to outline the endocardial and epicardial borders using in-house dedicated software MC-ROI 
(Interactive Data Language, version 6.1, Exelis Visual Information Solutions, Boulder, 
Colorado). 
Statistical analysis  
All analyses were performed using Matlab 2014a and R 3.2.3. Data normality was checked 
using Shapiro-Wilks test. The homogeneity of variance of data was evaluated using the 
Levene’s test.  
Student’s t-test was used for comparison of continuous variables (EF, EDV, ESV and LGE) 
measured at 2 time points (paired) and for variable MBF between two groups at a single time 
point (unpaired). P-values less than 0.05 were considered statistically significant. Correlation 
was expressed as Pearson's product moment correlation coefficient. 
Using 80% of the ROIs from the acute scans in the derivation cohort as a training set, a 
classification tree model optimized using 10 fold cross-validation for tree complexity, was 
adopted to determinate acute T1 cut-off values for remote tissue, reversible, and irreversible 
injury.11,12 The prediction accuracy of such T1 values was assessed on the remaining 20% ROIs 
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in the derivation cohort.13 Bland-Altman analysis was used to assess agreement of volume 
percentage of irreversible damaged tissue identified on LGE 6M versus threshold based acute 
T1 mapping analysis in validation cohort.  
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Figure S1. T1 comparison with LGE transmurality. Mean T1(LGEpos) ROIs is independent of 
mean acute LGE transmurality (p=0.89). 
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